Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

1. Cortés-Hernández, J.
2. Marras Fernández-Cid, C.
3. Andreu Sánchez, J.L.
4. Calvo Alén, J.
5. García-Aparicio, A.M.
6. Díez Álvarez, E.
7. Hidalgo Bermejo, F.J.
8. Coronell, C.
9. Perna, A.
10. Ordi Ros, J.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.REUMA.2022.08.001 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus